{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:47:01Z","timestamp":1789595221900,"version":"build-2803163510"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["205200002"],"award-info":[{"award-number":["205200002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>The favorable treatment outcome rate for multidrug-resistant tuberculosis (MDR-TB) is only 54%, and therefore new drug regimens are urgently needed. In this study, we evaluated the activity of the combination of moxifloxacin and linezolid as a possible new MDR-TB regimen in a murine TB model and the value of the addition of the efflux pump inhibitor verapamil to this backbone.<\/jats:p>","DOI":"10.1128\/aac.01354-18","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T10:02:52Z","timestamp":1530871372000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model"],"prefix":"10.1128","volume":"62","author":[{"given":"Elise D.","family":"Pieterman","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey H. M.","family":"te Brake","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands"},{"name":"Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjo J.","family":"de Knegt","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart","family":"van der Meijden","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Centre Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore I.","family":"Bax","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands"},{"name":"Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob E.","family":"Aarnoutse","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurriaan E. M.","family":"de Steenwinkel","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Global tuberculosis report","author":"WHO","year":"2017","unstructured":"WHO. 2017. Global tuberculosis report 2017.1. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006914"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70139-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.360-362.2003"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.653-657.2003"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201510-690BC"},{"key":"e_1_3_2_8_2","volume-title":"WHO treatment guidelines for drug-resistant tuberculosis","author":"WHO","year":"2016","unstructured":"WHO. 2016. WHO treatment guidelines for drug-resistant tuberculosis 2016 update 2016.7. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.65.240"},{"key":"e_1_3_2_10_2","first-page":"603","article-title":"Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis","volume":"7","author":"Zhang X","year":"2015","unstructured":"Zhang X, Falagas ME, Vardakas KZ, Wang R, Qin R, Wang J, Liu Y. 2015. Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. J Thorac Dis 7:603\u2013615.","journal-title":"J Thorac Dis"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00120-13"},{"key":"e_1_3_2_12_2","volume-title":"abstr 80LB","author":"Conradie FDA","year":"2017","unstructured":"Conradie FDA, Everitt D, Mendel C, van Niekerk C, Howell P, Comins K, Spigelman M. 2017. The NIX-TB trial of pretomanid, bedaquiline and linezolid to treat XDR-TB, abstr 80LB. Abstr Conf Retroviruses Opportunistic Infect, Seattle, WA, USA."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu095"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109769"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010617-052438"},{"key":"e_1_3_2_16_2","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo T","year":"1981","unstructured":"Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. 1981. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967\u20131972.","journal-title":"Cancer Res"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1047-1051.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00330"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034538"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01482-12"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1924OC"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104913.75206.62"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0210-4806(04)73094-6"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04271-14"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0650OC"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04019-14"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01692-17"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00022912"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201964"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.08.005"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.07.003"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw473"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.11.027"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01253-08"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2126"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176610"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70264-5"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.2165\/11532080-000000000-00000"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1843-1846.2001"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199200441-00002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.223"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00751-17"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00414-06"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00124-12"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1804.110912"},{"key":"e_1_3_2_46_2","volume-title":"Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard","author":"CLSI","year":"2012","unstructured":"CLSI. 2012. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard\u20142nd ed, 31. CLSI, Wayne, PA.","edition":"2"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200318"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09177-2"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01691-15"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.3.135"},{"key":"e_1_3_2_51_2","first-page":"3","article-title":"A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum","volume":"14","author":"Harmelink IM","year":"2008","unstructured":"Harmelink IM, Alffenaar JW, Wessels AM, Greijdanus B, Uges DR. 2008. A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum. EJHP Sci 14:3\u20137.","journal-title":"EJHP Sci"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00447-09"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24067-x"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01354-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01354-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:20:33Z","timestamp":1645478433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01354-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1128\/AAC.01354-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01354-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"2018-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01354-18"}}